Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer,…
Meet RESI’s Network of Global Investors and Channel Partners This fall, the Redefining Early Stage Investments Conference (RESI) will expand to include…
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced today that the first…